Pain Patch Market by Type (Opioid & Non-Opioid), By Mode of Administration (Metered Dose & Microneedle Patches) and by Therapeutic Use (Pain relief, Anaesthesia, Cough Suppression, Smoking Cessation) - Global Forecast to 2023
The global Pain Patch market is expected to reach USD 30.95 billion by 2023 from USD 24.25 billion in 2018, growing at a CAGR of 5.0%. Rising usage of opioids in non-cancer conditions and favourable reimbursement policies, increasing research and development in this field, favourable reimbursement facilities for palliative care in North American and European countries are some factors also promoting growth.
North America is a leader in this market owing to increasing geriatric population with rheumatoid arthritis. In addition, rising adoption of opioids for pain management related to injury and trauma in severe and chronic disabling diseases and in cases of postsurgical pain is driving market growth in North America.
Asia Pacific is expected to witness fastest growth in the future owing to highest geriatric population base. In addition, rise in healthcare expenditure are expected to drive the Asian market. Moreover, increasing government initiatives to raise awareness regarding benefits of opioids in management is likely to drive this market.
Key companies operating in this market include, Purdue Pharma L.P., Janssen Pharmaceuticals, Inc., West-Ward Pharmaceuticals Corporation, Pfizer, Inc., Allergan Plc (Actavis), Sanofi-Aventis S.A., Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co.,Inc. and Mylan N.V.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
This research report covers the global pain patch market; end user; and geography.
- Pain Patch Market, by Type
- Opioid Patches
- Immediate-Release
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Extended-Release
- xycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Non Opioid Patches
- Diclofenac Patches
- Methyl Salicylate Patches
- Capsaicin Patches
- Ketoprofen Patches
- Others
- Immediate-Release
- Opioid Patches
- Pain Patch Market, by Mode of Administration
- Minimally Invasive Microneedle Patches
- Metered Doses
- Active Delivery Systems With Patches
- Pain Patch Market, by Therapeutic Use
- Pain relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- Smoking Cessation
- Pain Patch Market, by Region
- North america
- US
- Canada
- Europe
- Germany
- Uk
- France
- Italy
- Rest of europe (RoE)
- Asia pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Rest of the World (Row)
- North america
Table of Contents
1 Introduction
2 Research Methodology
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
5 Pain Patch Market, By Type
5.1 Introduction
5.1.1 Opioid Patches
5.1.1.1 Immediate-Release
5.1.1.1.1 Codeine
5.1.1.1.2 Oxycodone
5.1.1.1.3 Hydrocodone
5.1.1.1.4 Fentanyl
5.1.1.1.5 Morphine
5.1.1.1.6 Hydroxymorphone
5.1.1.1.7 Oxymorphone
5.1.1.1.8 Propoxyphene
5.1.1.1.9 Others
5.1.1.2 Extended-Release
5.1.1.2.1 Xycodone
5.1.1.2.2 Hydrocodone
5.1.1.2.3 Methadone
5.1.1.2.4 Fentanyl
5.1.1.2.5 Morphine
5.1.1.2.6 Oxymorphone
5.1.1.2.7 Tapentadol
5.1.1.2.8 Buprenorphine
5.1.1.2.9 Hydromorphone
5.1.1.2.10 Others
5.1.2 Non Opioid Patches
5.1.2.1 Diclofenac Patches
5.1.2.2 Methyl Salicylate Patches
5.1.2.3 Capsaicin Patches
5.1.2.4 Ketoprofen Patches
5.1.2.5 Others
6 Pain Patch Market, By Mode of Administration
6.1 Introduction
6.2 Minimally Invasive Microneedle Patches
6.3 Metered Doses
6.4 Active Delivery Systems With Patches
6.5 Others (If Any)
7 Pain Patch Market, By Therapeutics Use
7.1 Introduction
7.2 Pain Relief
7.3 Anesthesia
7.4 Cough Suppression
7.5 Diarrhea Suppression
7.6 Smoking Cessation
7.7 Others (If Any)
8 Pain Patch Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 U.K
8.3.2 Germany
8.3.3 France
8.3.4 Rest of Europe (RoE)
8.4 Asia-Pacific
8.4.1 China
8.4.2 India
8.4.3 RoAPAC
8.5 Rest of the World (RoW)
9 Pain Patch Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Ambulatory Surgical Centers
9.4 Other End Users
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
9.3.1 Agreements & Partnerships
9.3.2 Acquisitions
9.3.3 Expansions
9.3.4 New Product Launches
9.3.5 Other Developments
10 Company Profiles
10.1 Introduction
10.2 Blue Wave Ultrasonics
10.2.1 Business Overview
10.2.2 Company Snapshot
10.2.3 Products and Services
10.2.4 Recent Developments
10.2.5 MnM View
10.3 L&R Manufacturing
10.4 Mettler Electronics
10.5 Sharpertek
10.6 Analab Scientific
10.7 Namrol Group
10.8 US Opthalmic
10.9 Dent Geosoft
10.10 Endo-Technik
10.11 Steelco Spa
11 Appendix
Note:
1 Above Segmentation May Change During the Course of Planned Research Work.
2 Financials, Recent Developments Might Not Be Captured in Case of Unlisted Companies.
3 Above List of Companies is Tentative. It May Change During the Planned Research Work. However, We Will Profile Only 10 Companies.
Growth opportunities and latent adjacency in Pain Patch Market